Back to calendar
Halozyme Therapeutics, Inc. (HALO) Earnings
HALO reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026 · After Market Close
Q2 2026
Est. EPS: $2.24
Actual EPS: $2.28
EPS surprise: 27.58%
Company overview
Market Cap$11.6B
PriceUSD 102.05
P/E30.49
EPS (TTM)3.35
52-week high104.78
52-week low61.23
SectorHealth Technology
IndustryBiotechnology
Employees423